Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | O'Loan RonanChief Human Resources Officer | Tax withholding | F | $2,521 7,877 sh | Apr 13, 2026 |
| 9 | Nierenberg EricEVP, CFO AND TREASURER | Grant or award | A | — 911 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Quain Mitchell IDirector | Grant or award | A | — 3,007 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Botelho Kiersten ZazaChief Legal Officer & CCO | Tax withholding | F | $15K 1,018 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Chen Feng-HuaChief Operating Officer | Grant or award | A | — 100.0K sh | Apr 13, 2026 traded Apr 13, 2026 |
| 9 | Meyer Seth HChief Financial Officer | Tax withholding | F | $44K 3,011 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Esch KevinExecutive Vice President | Grant or award | A | $55.28 1 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Langan BrianSee Remarks | Grant or award | A | — 911 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Follmann ChristianChief Operating Officer | Tax withholding | F | $21K 1,433 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Gray James DChief Financial Officer | Grant or award | A | — 99.7K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Wirfel MichelleEVP, Chief Operating Officer | Tax withholding | F | $2,831 154 sh | Apr 13, 2026 traded Apr 12, 2026 |
| 9 | Laughter John EEVP & Chief of Operations | Option exercise | M | — 13.5K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Holmes Chad MEVP AND CHIEF CORP DEV OFFICER | Grant or award | A | — 1,579 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Hoeflinger ErinDirector | Grant or award | A | $24K 1,698 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Filson Sean AndrewDirector | Grant or award | A | — 100.0K sh | Apr 13, 2026 traded Apr 13, 2026 |
| 9 | Follmann ChristianChief Operating Officer | Tax withholding | F | $20K 1,365 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Solomon Lance I.Chief Product Officer | Tax withholding | F | $3,414 10.7K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Yellin Jonathan DEVP AND GENERAL COUNSEL | Grant or award | A | — 1,396 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Panzara Michael A.Director | Grant or award | A | — 28.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Laughter John EEVP & Chief of Operations | Option exercise | M | — 9,080 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Litton Mark JamesDirector, PRESIDENT and CEO | Grant or award | A | — 750.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Bolton JeffreyDirector | Grant or award | A | $37K 2,680 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Krause Allyson G.General Counsel | Tax withholding | F | $6,646 20.8K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Gray James DChief Financial Officer | Grant or award | A | — 99.7K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Warzala Richard SDirector | Grant or award | A | — 2,827 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Church KevinCHIEF SCIENTIFIC OFFICER | Grant or award | A | — 300.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Kosacz BarbaraDirector | Grant or award | A | — 28.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Creed GregDirector | Grant or award | A | $34K 787 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 8 | O'Connor CaseyChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $185K 60.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 8 | Moat RossCHIEF OPERATING OFFICER | Open-market sale · 10b5-1 plan | SELL | $80K 1,703 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 7 | Howard Justyn RussellDirector, Executive Chair, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 40.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 6 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $59K 2,170 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Shetty Reshma P.Director, See remarks, 10% Owner | Option exercise | M | — 251.8K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Canton Barry10% Owner | Option exercise | M | — 251.8K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Freemen-Bosworth LaurenEVP/Gen Counsel & Corp Sec | Open-market sale · 10b5-1 plan | SELL | $7,970 693 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 5 | Renninger RobertCHIEF FINANCIAL OFFICER | Grant or award | A | — 300.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Pomel OlivierDirector, Chief Executive Officer | Option exercise · 10b5-1 plan | M | $384K 35.7K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 4 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | — 3,093 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 4 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 4 | Perducat CyrilSVP, Chief Technology Officer | Option exercise · 10b5-1 plan | M | — 581 sh | Apr 13, 2026 traded Apr 9, 2026 |